After COVID-19 Showcased the “Power of Science,” J&J Exec Urges Industry to Start Thinking “Cure” in Cancer

Prior to the COVID-19 Plandemic, cancer and cancer drugs were the biggest financial revenue streams in Big Pharma. Even at the height of the manufactured COVID-19 Plandemic, with all of the corruption involved in elevating the death statistics to try and make every death look like it was caused by COVID-19, there were still more people dying from cancer. As we have reported over the past decade, this industry is far too profitable to allow a cure, and we recently re-published the documentary: Cancer: The Forbidden Cures.  But now, apparently taking their cue from COVID-19 "cures" and RNA "vaccines" which look to be ongoing products they can indefinitely inject into people to provide a steady income stream, for the first time those in the lucrative cancer industry are beginning to use the forbidden word: "cure." The pharmaceutical trade publication, FiercePharma, published an article yesterday where they quoted Peter Lebowitz, M.D., Ph.D., Janssen's (J&J) global oncology therapeutic head, at the virtual BIO Digital 2021 conference earlier this week. "Looking forward, Lebowitz said researchers and companies should think about a word the industry has sometimes avoided: a cure." "When I started off in my career, people wouldn’t say the word 'cure,'" Lebowitz told Scrip Intelligence's Mandy Jackson during the fireside chat. “They wouldn’t talk about cures.” Of course they wouldn't! Because actual cures to cancer, such as the ones the FDA banned and chased out of the country where one now needs to go to Mexico or Europe to get them, is bad for business. And while Big Pharma denied this fact for years, while collecting millions of dollars each year from the contributions of every-day Americans to their favorite cancer "charity" which helped fund drug research, we now have a major cancer scientist admitting that they never discussed cures to begin with.